PRCT vs. PSEC
PRCT (PROCEPT BioRobotics Corporation) and PSEC (Prospect Capital Corporation) are both stocks. PRCT operates in Medical Devices (Healthcare), while PSEC operates in Asset Management (Financial Services). Over the past 3 years, PRCT returned -14.75%/yr vs -16.49%/yr for PSEC. At a 0.26 correlation, their price movements are largely independent.
Performance
PRCT vs. PSEC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PRCT achieves a -34.52% return, which is significantly lower than PSEC's -4.94% return.
PRCT
- 1D
- -2.18%
- 1M
- -28.97%
- YTD
- -34.52%
- 6M
- -37.04%
- 1Y
- -64.93%
- 3Y*
- -14.75%
- 5Y*
- —
- 10Y*
- —
PSEC
- 1D
- 0.89%
- 1M
- 1.09%
- YTD
- -4.94%
- 6M
- 2.32%
- 1Y
- -12.88%
- 3Y*
- -16.49%
- 5Y*
- -13.74%
- 10Y*
- -0.18%
PRCT vs. PSEC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
PRCT PROCEPT BioRobotics Corporation | -34.52% | -60.93% | 92.13% | 0.89% | 66.09% | -28.54% |
PSEC Prospect Capital Corporation | -4.94% | -28.86% | -18.16% | -4.13% | -8.61% | 12.51% |
Correlation
The correlation between PRCT and PSEC is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Sep 15, 2021 | 0.26 |
Fundamentals
PRCT:
-$2.46
PSEC:
-$0.28
PRCT:
2.67
PSEC:
5.11
PRCT:
$322.02M
PSEC:
$151.90M
PRCT:
$206.01M
PSEC:
-$59.07M
PRCT:
-$90.33M
PSEC:
-$94.23M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PRCT vs. PSEC — Risk / Return Rank
PRCT
PSEC
PRCT vs. PSEC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for PROCEPT BioRobotics Corporation (PRCT) and Prospect Capital Corporation (PSEC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PRCT | PSEC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.68 | ||
| Sortino ratioReturn per unit of downside risk | -1.58 | ||
| Omega ratioGain probability vs. loss probability | 0.79 | 0.96 | -0.17 |
| Calmar ratioReturn relative to maximum drawdown | -0.99 | -0.48 | -0.51 |
| Martin ratioReturn relative to average drawdown | -1.40 | -0.84 | -0.56 |
Loading charts...
Drawdowns
PRCT vs. PSEC - Drawdown Comparison
The maximum PRCT drawdown since its inception was -79.29%, which is greater than PSEC's maximum drawdown of -61.51%. Use the drawdown chart below to compare losses from any high point for PRCT and PSEC.
Loading charts...
Drawdown Indicators
| PRCT | PSEC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -79.29% | -61.51% | -17.78% |
Max Drawdown (1Y)Largest decline over 1 year | -65.70% | -27.04% | -38.66% |
Max Drawdown (3Y)Largest decline over 3 years | -79.29% | -50.64% | -28.65% |
Max Drawdown (5Y)Largest decline over 5 years | — | -57.21% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -57.21% | — |
Current DrawdownCurrent decline from peak | -79.29% | -54.13% | -25.16% |
Average DrawdownAverage peak-to-trough decline | -32.11% | -15.69% | -16.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 46.45% | 15.40% | +31.05% |
Volatility
PRCT vs. PSEC - Volatility Comparison
PROCEPT BioRobotics Corporation (PRCT) has a higher volatility of 19.09% compared to Prospect Capital Corporation (PSEC) at 10.14%. This indicates that PRCT's price experiences larger fluctuations and is considered to be riskier than PSEC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PRCT | PSEC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.09% | 10.14% | +8.95% |
Volatility (6M)Calculated over the trailing 6-month period | 48.21% | 27.53% | +20.68% |
Volatility (1Y)Calculated over the trailing 1-year period | 61.33% | 33.89% | +27.44% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 65.55% | 27.99% | +37.56% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 65.55% | 27.39% | +38.16% |
Dividends
PRCT vs. PSEC - Dividend Comparison
PRCT has not paid dividends to shareholders, while PSEC's dividend yield for the trailing twelve months is around 23.35%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRCT PROCEPT BioRobotics Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PSEC Prospect Capital Corporation | 23.35% | 20.85% | 16.01% | 12.02% | 10.30% | 8.56% | 13.31% | 11.18% | 11.41% | 13.45% | 11.98% | 14.72% |
Financials
PRCT vs. PSEC - Financials Comparison
This section allows you to compare key financial metrics between PROCEPT BioRobotics Corporation and Prospect Capital Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PRCT vs. PSEC - Profitability Comparison
PRCT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, PROCEPT BioRobotics Corporation reported a gross profit of 53.95M and revenue of 83.13M. Therefore, the gross margin over that period was 64.9%.
PSEC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Prospect Capital Corporation reported a gross profit of 0.00 and revenue of 123.07M. Therefore, the gross margin over that period was 0.0%.
PRCT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, PROCEPT BioRobotics Corporation reported an operating income of -32.61M and revenue of 83.13M, resulting in an operating margin of -39.2%.
PSEC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Prospect Capital Corporation reported an operating income of 0.00 and revenue of 123.07M, resulting in an operating margin of 0.0%.
PRCT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, PROCEPT BioRobotics Corporation reported a net income of -31.64M and revenue of 83.13M, resulting in a net margin of -38.1%.
PSEC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Prospect Capital Corporation reported a net income of 0.00 and revenue of 123.07M, resulting in a net margin of 0.0%.
Frequently Asked Questions
PRCT and PSEC have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PRCT has higher volatility (19.09%) compared to PSEC (10.14%). In terms of maximum drawdown, PRCT dropped -79.29% vs PSEC's -61.51%.
PSEC currently has the higher Sharpe Ratio (-0.38 vs -1.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PRCT and PSEC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer